141 related articles for article (PubMed ID: 33180328)
1. Global loss of Tfr2 with concomitant induced iron deficiency greatly ameliorates the phenotype of a murine thalassemia intermedia model.
Schmidt PJ; Fitzgerald K; Butler JS; Fleming MD
Am J Hematol; 2021 Feb; 96(2):251-257. PubMed ID: 33180328
[TBL] [Abstract][Full Text] [Related]
2. Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice.
Guo S; Casu C; Gardenghi S; Booten S; Aghajan M; Peralta R; Watt A; Freier S; Monia BP; Rivella S
J Clin Invest; 2013 Apr; 123(4):1531-41. PubMed ID: 23524968
[TBL] [Abstract][Full Text] [Related]
3. Regulation of iron homeostasis by hepatocyte TfR1 requires HFE and contributes to hepcidin suppression in β-thalassemia.
Xiao X; Moschetta GA; Xu Y; Fisher AL; Alfaro-Magallanes VM; Dev S; Wang CY; Babitt JL
Blood; 2023 Jan; 141(4):422-432. PubMed ID: 36322932
[TBL] [Abstract][Full Text] [Related]
4. Transferrin receptor 2 (Tfr2) genetic deletion makes transfusion-independent a murine model of transfusion-dependent β-thalassemia.
Di Modica SM; Tanzi E; Olivari V; Lidonnici MR; Pettinato M; Pagani A; Tiboni F; Furiosi V; Silvestri L; Ferrari G; Rivella S; Nai A
Am J Hematol; 2022 Oct; 97(10):1324-1336. PubMed ID: 36071579
[TBL] [Abstract][Full Text] [Related]
5. DENND3 p.L708V activating variant is involved in the pathogenesis of hereditary hemochromatosis via the RAB12/TFR2 signaling pathway.
Li Y; Xu A; Ouyang Q; Zhang W; Zhang C; Chen Z; Zhou D; Zhang B; Duan W; Zhao X; Wang X; You H; Ou X; Jia J; Huang J
Hepatol Int; 2023 Jun; 17(3):648-661. PubMed ID: 36729283
[TBL] [Abstract][Full Text] [Related]
6. New Mutations in
Hernández G; Ferrer-Cortès X; Venturi V; Musri M; Pilquil MF; Torres PMM; Rodríguez IH; Mínguez MÀR; Kelleher NJ; Pelucchi S; Piperno A; Alberca EP; Ricós GG; Giró EC; Pérez-Montero S; Tornador C; Villà-Freixa J; Sánchez M
Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946929
[TBL] [Abstract][Full Text] [Related]
7. Effect of Erythropoietin, Iron Deficiency and Iron Overload on Liver Matriptase-2 (TMPRSS6) Protein Content in Mice and Rats.
Frýdlová J; Přikryl P; Truksa J; Falke LL; Du X; Gurieva I; Vokurka M; Krijt J
PLoS One; 2016; 11(2):e0148540. PubMed ID: 26845567
[TBL] [Abstract][Full Text] [Related]
8. Altered Erythropoiesis in Mouse Models of Type 3 Hemochromatosis.
Pellegrino RM; Riondato F; Ferbo L; Boero M; Palmieri A; Osella L; Pollicino P; Miniscalco B; Saglio G; Roetto A
Biomed Res Int; 2017; 2017():2408941. PubMed ID: 28540293
[TBL] [Abstract][Full Text] [Related]
9. A human anti-matriptase-2 antibody limits iron overload, α-globin aggregates, and splenomegaly in β-thalassemic mice.
Wake M; Palin A; Belot A; Berger M; Lorgouilloux M; Bichon M; Papworth J; Bayliss L; Grimshaw B; Rynkiewicz N; Paterson J; Poindron A; Spearing E; Carter E; Hudson R; Campbell M; Petzer V; Besson-Fournier C; Latour C; Largounez A; Gourbeyre O; Fay A; Coppin H; Roth MP; Theurl I; Germaschewski V; Meynard D
Blood Adv; 2024 Apr; 8(8):1898-1907. PubMed ID: 38241484
[TBL] [Abstract][Full Text] [Related]
10. TMPRSS6 as a Therapeutic Target for Disorders of Erythropoiesis and Iron Homeostasis.
Ganz T; Nemeth E; Rivella S; Goldberg P; Dibble AR; McCaleb ML; Guo S; Monia BP; Barrett TD
Adv Ther; 2023 Apr; 40(4):1317-1333. PubMed ID: 36690839
[TBL] [Abstract][Full Text] [Related]
11. New thiazolidinones reduce iron overload in mouse models of hereditary hemochromatosis and β-thalassemia.
Liu J; Liu W; Liu Y; Miao Y; Guo Y; Song H; Wang F; Zhou H; Ganz T; Yan B; Liu S
Haematologica; 2019 Sep; 104(9):1768-1781. PubMed ID: 30792208
[TBL] [Abstract][Full Text] [Related]
12. Regulation of type II transmembrane serine proteinase TMPRSS6 by hypoxia-inducible factors: new link between hypoxia signaling and iron homeostasis.
Lakhal S; Schödel J; Townsend AR; Pugh CW; Ratcliffe PJ; Mole DR
J Biol Chem; 2011 Feb; 286(6):4090-7. PubMed ID: 20966077
[TBL] [Abstract][Full Text] [Related]
13. Erythroferrone exacerbates iron overload and ineffective extramedullary erythropoiesis in a mouse model of β-thalassemia.
Olivera J; Zhang V; Nemeth E; Ganz T
Blood Adv; 2023 Jul; 7(14):3339-3349. PubMed ID: 36995275
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow Tfr2 deletion improves the therapeutic efficacy of the activin-receptor ligand trap RAP-536 in β-thalassemic mice.
Tanzi E; Di Modica SM; Bordini J; Olivari V; Pagani A; Furiosi V; Silvestri L; Campanella A; Nai A
Am J Hematol; 2024 Apr; ():. PubMed ID: 38629683
[TBL] [Abstract][Full Text] [Related]
15. Managing the Dual Nature of Iron to Preserve Health.
Silvestri L; Pettinato M; Furiosi V; Bavuso Volpe L; Nai A; Pagani A
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835406
[TBL] [Abstract][Full Text] [Related]
16. Cardiac
Bigorra Mir M; Charlebois E; Tsyplenkova S; Fillebeen C; Pantopoulos K
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982241
[TBL] [Abstract][Full Text] [Related]
17. A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease.
Olivari V; Di Modica SM; Lidonnici MR; Aghajan M; Cordero-Sanchez C; Tanzi E; Pettinato M; Pagani A; Tiboni F; Silvestri L; Guo S; Ferrari G; Nai A
Kidney Int; 2023 Jul; 104(1):61-73. PubMed ID: 36990212
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome analysis reveals TMPRSS6 isoforms with distinct functionalities.
Dion SP; Béliveau F; Désilets A; Ghinet MG; Leduc R
J Cell Mol Med; 2018 Apr; 22(4):2498-2509. PubMed ID: 29441715
[TBL] [Abstract][Full Text] [Related]
19. Genetic Iron Overload Hampers Development of Cutaneous Leishmaniasis in Mice.
Charlebois E; Li Y; Wagner V; Pantopoulos K; Olivier M
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675185
[TBL] [Abstract][Full Text] [Related]
20. A functional interplay between the two BMP-SMAD pathway inhibitors TMPRSS6 and FKBP12 regulates
Pettinato M; Aghajan M; Guo S; Bavuso Volpe L; Carleo R; Nai A; Pagani A; Altamura S; Silvestri L
Am J Physiol Gastrointest Liver Physiol; 2024 Mar; 326(3):G310-G317. PubMed ID: 38252872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
